Garware Fulflex Expands Global Healthcare Footprint with Acquisition of State-of-the-Art Medical Manufacturing Facility in Jacksonville, Texas

Garware Fulflex has recently completed the acquisition of a 300,000-square-foot medical products manufacturing facility in Jacksonville, Texas, as part of its global healthcare growth strategy. The facility, located on a 30-acre campus, employs over 250 people and produces a wide range of critical medical products using advanced manufacturing technologies such as injection molding, blow molding, and thermoforming. This acquisition is expected to double Garware Fulflex's global revenue and enhance its position as a leading healthcare manufacturing company.
Diya Garware Ibanez, the Chairperson of Garware Fulflex, expressed excitement about the acquisition, highlighting the facility's talented workforce, cutting-edge manufacturing capabilities, and strategic location in the North American healthcare market. The addition of the Jacksonville facility strengthens Garware Fulflex's global manufacturing network, providing customers with increased production capacity, technical expertise, and supply chain resilience.
Garware Fulflex, a global healthcare manufacturing company based in India, specializes in medical products and engineered polymer solutions. With operations in 14 locations worldwide, including manufacturing facilities in the United States, the Dominican Republic, and India, the company serves customers in over 85 countries. The acquisition of the Jacksonville facility further solidifies Garware Fulflex's commitment to delivering innovative and high-quality healthcare solutions to its global clientele.
For media inquiries, please contact Monica Mantri at [email protected].